BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4130904)

  • 61. Reversible myelofibrosis?
    Lancet; 1985 Mar; 1(8427):497-9. PubMed ID: 2857858
    [No Abstract]   [Full Text] [Related]  

  • 62. [Lysosomes in blood cells as diagnostic parameter (author's transl)].
    Stutte HJ; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1976; ():155-75. PubMed ID: 1022073
    [No Abstract]   [Full Text] [Related]  

  • 63. Megakaryocytes in serous effusions.
    Vilaseca J; Arnau JM; Tallada N; Salas A
    J Clin Pathol; 1981 Aug; 34(8):939. PubMed ID: 7276214
    [No Abstract]   [Full Text] [Related]  

  • 64. NCCN News.
    J Natl Compr Canc Netw; 2016 Dec; 14(12):xxviii-xl. PubMed ID: 27956546
    [No Abstract]   [Full Text] [Related]  

  • 65. Introduction to 'Spotlight on myeloproliferative neoplasms'.
    Muller-Berat Killmann CN
    Leukemia; 2008 Jan; 22(1):2. PubMed ID: 18197172
    [No Abstract]   [Full Text] [Related]  

  • 66. p53 as a target in myeloproliferative neoplasms.
    Lu M; Hoffman R
    Oncotarget; 2012 Oct; 3(10):1052-3. PubMed ID: 23165648
    [No Abstract]   [Full Text] [Related]  

  • 67. Mechanism of myelofibrosis in chronic myeloproliferative disorders.
    Yonekura S
    Tokai J Exp Clin Med; 1987 Sep; 12(3):141-5. PubMed ID: 3331217
    [No Abstract]   [Full Text] [Related]  

  • 68. Myelofibrosis in myeloproliferative disorders.
    Srinivasan U; Talvalkar GV; Advani SH
    Indian J Cancer; 1978 Sep; 15(3):37-43. PubMed ID: 294411
    [No Abstract]   [Full Text] [Related]  

  • 69. [Problems of the myeloproliferative syndrome from the pathologist's viewpoint].
    Werner W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(2):227-34. PubMed ID: 4184585
    [No Abstract]   [Full Text] [Related]  

  • 70. Abnormal clones of megakaryocytes in myeloproliferative disorders.
    Sato Y; Suda T
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1705-18. PubMed ID: 3471029
    [No Abstract]   [Full Text] [Related]  

  • 71. [Osteomyelofibrosis as a prognostic factor in myeloproliferative diseases?].
    Wehmeier A; Schneider W
    Dtsch Med Wochenschr; 1993 May; 118(21):804-5. PubMed ID: 8504717
    [No Abstract]   [Full Text] [Related]  

  • 72. [Bioptic medullary findings for the formation of fibres in attended and not yet attended myeloses (author's transl)].
    Hill K; Dennhardt HH
    Verh Dtsch Ges Pathol; 1972; 56():587-92. PubMed ID: 4130904
    [No Abstract]   [Full Text] [Related]  

  • 73. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.
    Wilkins BS
    Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.